QLT Announces Positive Preliminary Results From Phase 1b Retreatment Trial of QLT091001 in Subjects With Leber Congenital Amaurosis and Retinitis Pigmentosa Due to Mutations in LRAT or RPE65
February 27, 2014 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, Feb. 27, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced positive preliminary results from its international,...
QLT Announces First Patient Dosed in Phase IIa Proof-of-Concept Trial for QLT091001 in Impaired Dark Adaptation
December 09, 2013 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, Dec. 9, 2013 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that the first patient has been dosed in the Company's Phase IIa...
QLT Announces Oral Retinoid Program Clinical and Regulatory Update, and Review of Strategic Alternatives
November 20, 2013 16:01 ET
|
QLT Inc.
Plans for Phase IIa Proof-of-Concept Trial for QLT091001 in Impaired Dark Adaptation
Company to Provide Guidance on Pivotal Studies in Orphan Indications Before the End of Q1 2014
VANCOUVER,...
QLT Announces Resignation of Vicente Anido, Jr. as Director
November 11, 2013 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, Nov. 11, 2013 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that Vicente Anido, Jr. has resigned from the Board of...
QLT Announces Third Quarter 2013 Results
November 07, 2013 07:00 ET
|
QLT Inc.
VANCOUVER, British Columbia, Nov. 7, 2013 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization of...
QLT Announces Second Quarter 2013 Results
August 01, 2013 07:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, Aug. 1, 2013 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization of...
QLT Announces Completion of US$200 Million Special Cash Distribution to Shareholders
June 27, 2013 17:29 ET
|
QLT Inc.
VANCOUVER, British Columbia, June 27, 2013 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is pleased to announce that the Company has completed today the previously...
QLT Announces Shareholder Approval of US$200 Million Special Cash Distribution to Shareholders and Election Results
June 14, 2013 16:25 ET
|
QLT Inc.
VANCOUVER, British Columbia, June 14, 2013 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is pleased to announce that at the annual general and special meeting (the...
QLT Announces First Quarter 2013 Results
May 02, 2013 07:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, May 2, 2013 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization of...
QLT Proposes US$200 Million Special Cash Distribution to Shareholders
April 15, 2013 07:30 ET
|
QLT Inc.
Cash Distribution Free of Canadian Withholding Taxes
Follows the US$27 Million Already Returned to Shareholders via QLT's NCIB Share Repurchase Program
QLT Board Will...